Rebecca C Schugar1, Peter A Crawford. 1. Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St Louis, Missouri, USA.
Abstract
PURPOSE OF REVIEW: Obesity-associated nonalcoholic fatty liver disease (NAFLD) is highly prevalent, for which weight loss is the generally recommended clinical management. Low-carbohydrate ketogenic diets have been successful in promoting weight loss, but variations in the range of metabolic responses to these diets indicate that the effects of altering macronutrient content are not completely understood. This review focuses on the most recent findings that reveal the relationship between low-carbohydrate diets and NAFLD in rodent models and humans. RECENT FINDINGS: Low-carbohydrate diets have been shown to promote weight loss, decrease intrahepatic triglyceride content, and improve metabolic parameters of patients with obesity. These ketogenic diets also provoke weight loss in rodents. However, long-term maintenance on a ketogenic diet stimulates the development of NAFLD and systemic glucose intolerance in mice. The relationship between ketogenic diets and systemic insulin resistance in both humans and rodents remains to be elucidated. SUMMARY: Because low-carbohydrate ketogenic diets are increasingly employed for treatment of obesity, NAFLD, and neurological diseases such as epilepsy, understanding the long-term systemic effects of low-carbohydrate diets is crucial to the development of efficacious and safe dietary interventions.
PURPOSE OF REVIEW: Obesity-associated nonalcoholic fatty liver disease (NAFLD) is highly prevalent, for which weight loss is the generally recommended clinical management. Low-carbohydrate ketogenic diets have been successful in promoting weight loss, but variations in the range of metabolic responses to these diets indicate that the effects of altering macronutrient content are not completely understood. This review focuses on the most recent findings that reveal the relationship between low-carbohydrate diets and NAFLD in rodent models and humans. RECENT FINDINGS:Low-carbohydrate diets have been shown to promote weight loss, decrease intrahepatictriglyceride content, and improve metabolic parameters of patients with obesity. These ketogenic diets also provoke weight loss in rodents. However, long-term maintenance on a ketogenic diet stimulates the development of NAFLD and systemic glucose intolerance in mice. The relationship between ketogenic diets and systemic insulin resistance in both humans and rodents remains to be elucidated. SUMMARY: Because low-carbohydrate ketogenic diets are increasingly employed for treatment of obesity, NAFLD, and neurological diseases such as epilepsy, understanding the long-term systemic effects of low-carbohydrate diets is crucial to the development of efficacious and safe dietary interventions.
Authors: Francisco Caballero; Anna Fernández; Nuria Matías; Laura Martínez; Raquel Fucho; Montserrat Elena; Joan Caballeria; Albert Morales; José C Fernández-Checa; Carmen García-Ruiz Journal: J Biol Chem Date: 2010-04-15 Impact factor: 5.157
Authors: Hendrik A Marsman; Michal Heger; Jaap J Kloek; Syert L Nienhuis; Jochem R van Werven; Aart J Nederveen; Fiebo Jw Ten Kate; Jaap Stoker; Thomas M van Gulik Journal: J Gastroenterol Hepatol Date: 2011-02 Impact factor: 4.029
Authors: Joel R Garbow; Jason M Doherty; Rebecca C Schugar; Sarah Travers; Mary L Weber; Anna E Wentz; Nkiruka Ezenwajiaku; David G Cotter; Elizabeth M Brunt; Peter A Crawford Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-03-31 Impact factor: 4.052
Authors: Tadahiro Shimazu; Matthew D Hirschey; Lan Hua; Kristin E Dittenhafer-Reed; Bjoern Schwer; David B Lombard; Yu Li; Jakob Bunkenborg; Frederick W Alt; John M Denu; Matthew P Jacobson; Eric Verdin Journal: Cell Metab Date: 2010-12-01 Impact factor: 27.287
Authors: Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein Journal: Proc Natl Acad Sci U S A Date: 2009-08-24 Impact factor: 11.205
Authors: Laura H Tetri; Metin Basaranoglu; Elizabeth M Brunt; Lisa M Yerian; Brent A Neuschwander-Tetri Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-09-04 Impact factor: 4.052
Authors: Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga Journal: Chem Rev Date: 2013-04-10 Impact factor: 60.622
Authors: Mary P Moore; Rory P Cunningham; Ryan J Dashek; Justine M Mucinski; R Scott Rector Journal: Obesity (Silver Spring) Date: 2020-09-06 Impact factor: 5.002